JBM (Healthcare) Limited (02161.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 1.65

From 52W high−46.93%

Volume76000.00

Market capHKD 1.34B

P/E (TTM)6.6x

P/S (TTM)1.6x

Div yield10.43%

Key dataSep 18, 2026

Open

HKD 1.65

From 52W high

−46.93%

Volume

76000.00

Market cap

HKD 1.34B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

5.6x

P/E (TTM)

6.6x

RSI (14)

26.5

MomentumView details →

1D Return

+0.00%

YTD Return

−38.35%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

6.6x

EV/EBITDA

5.6x

EV/Sales

2.0x

P/S (TTM)

1.6x

P/B (TTM)

1.2x

ProfitabilityView details →

Gross Margin

55.78%

Net Margin

24.09%

EBITDA Margin

35.66%

ROE (TTM)

18.62%

ROA (TTM)

11.41%

Asset Turnover

0.47x

GrowthView details →

Revenue YoY

+6.69%

EPS YoY

+4.17%

FCF YoY

−42.04%

Revenue CAGR 3Y

+17.06%

EPS CAGR 3Y

+57.49%

EBITDA YoY

+4.96%

MomentumView details →

1D Return

+0.00%

YTD Return

−38.35%

1Y Return

−46.93%

RSI (14)

26.5

vs 50D SMA

−12.50%

vs 200D SMA

−31.57%

Capital & dividendView details →

Debt/Equity

0.36x

Current Ratio

1.90x

Quick Ratio

1.59x

Div Yield

10.43%

Div Rate

HKD 0.17

Div Growth 1Y

+122.51%

EarningsView details →

EPS (Actual)

HKD 0.12

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.62B

Net Income (TTM)

398.35M

Op. CF (TTM)

377.60M

Next earningsNov 17, 2026 →

Latest newsMore news →

JBM Healthcare (02161.HK) announced a proposed spin-off of its branded Chinese patent medicine and Chinese medicine clinic services business, including Po Chai Pills, for a separate listing on the Main Board of the Stock Exchange of Hong Kong via a global offering of Po Chai Yuan shares.62d ago

JBM (Healthcare) Limited recommended a final dividend of HK7.35 cents per share.90d ago

Similar companies

Jilin Province Huinan Changlong Bio-pharmacy Company Limited08049.HK Essex Bio-Technology Limited01061.HK Phibro Animal Health CorporationPAHC Golden Throat Holdings Group Company Limited06896.HK Harrow Health, Inc.HROW Cronos Group Inc.CRON Find similar companies →

Latest newsMore news →

JBM Healthcare (02161.HK) announced a proposed spin-off of its branded Chinese patent medicine and Chinese medicine clinic services business, including Po Chai Pills, for a separate listing on the Main Board of the Stock Exchange of Hong Kong via a global offering of Po Chai Yuan shares.62d ago JBM (Healthcare) Limited recommended a final dividend of HK7.35 cents per share.90d ago JBM (Healthcare) Limited announced its FY2026 annual results, reporting revenue growth of 6.7% and a 1.9% increase in profit attributable to shareholders.90d ago